SCHEMBL4244818

SCHEMBL4244818

CC(C)(Oc1cccc2c1ccn2CCCN1c2ccccc2Oc2ccccc21)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 10/20 0.53
PPARG P37231 10/20 0.51
PPARD Q03181 3/20 0.49
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MCL1 Q07820 5/20 0.39
BAD Q92934 2/20 0.39
BCL2 P10415 2/20 0.38
PLA2G2A P14555 1/20 0.37
SIGMAR1 Q99720 1/20 0.36
HDAC3 O15379 1/20 0.35
TUBB4A P04350 1/20 0.35
TUBB P07437 1/20 0.35
TUBA3C P0DPH7 1/20 0.35
HDAC4 P56524 1/20 0.35
TUBA1B P68363 1/20 0.35
TUBA4A P68366 1/20 0.35
TUBB4B P68371 1/20 0.35
TUBB3 Q13509 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4230153 0.98 PPARA (0.53) PPARAPPARGPPARDKDM4EALDH1A1
SCHEMBL4239452 0.86 PPARA (0.53) PPARAPPARGPPARDKDM4EALDH1A1
SCHEMBL4239918 0.82 PPARA (0.57) PPARAPPARGPPARDKDM4EALDH1A1
SCHEMBL5009209 0.76 PPARG (0.54) PPARAPPARGPPARDMCL1BAD
SCHEMBL4241584 0.76 PPARA (0.59) PPARAPPARGPPARDKDM4EALDH1A1
SCHEMBL5011262 0.76 PPARG (0.53) PPARAPPARGPPARDMCL1BAD
SCHEMBL4237875 0.75 PPARA (0.52) PPARAPPARGPPARDKDM4EALDH1A1
SCHEMBL4241790 0.75 PPARA (0.71) PPARAPPARGPPARDMCL1BAD
SCHEMBL4235265 0.74 PPARA (0.51) PPARAPPARGPPARDKDM4EALDH1A1
SCHEMBL4239732 0.73 PPARA (0.56) PPARAPPARGPPARDKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1689389-A4 INDOLE COMPOUNDS NAT HEALTH RESEARCH INSTITUTES (TW) 2009-06-17 EP disclosed
US-7449478-B2 Indole compounds NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-11-11 US disclosed
US-7449478-B2 Indole compounds NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-11-11 US disclosed
US-7449478-B2 Indole compounds NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-11-11 US disclosed
EP-1689389-A2 INDOLE COMPOUNDS National Health Research Institutes (TW) 2006-08-16 EP disclosed
WO-2005056522-A2 INDOLE COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2005-06-23 WO disclosed
US-20050124675-A1 Indole compounds NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2005-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124675-A1 Indole compounds PPARG, PPARD, PPARA PPARA 3/4885PPARG 1/4885PPARD 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.